RAPTOR Silencing Inhibits Head and Neck Squamous Cell Carcinoma Progression via Regulation of S100A8/A9 and Urokinase Plasminogen Activator

Zhenzhen Fu; Song Wang; Haoran Zheng; Huadong Wu; Tao Li; Lihao Wang; Hong Li; Qiang Zhang

doi:10.12659/MSM.952169

05 May 2026 : Animal Research

RAPTOR Silencing Inhibits Head and Neck Squamous Cell Carcinoma Progression via Regulation of S100A8/A9 and Urokinase Plasminogen Activator

Zhenzhen Fu^{BCDEF 1,2}, Song Wang^{BCDEF 3}, Haoran Zheng^{BCDEF 2}, Huadong Wu^{BCD 2}, Tao Li^{BCF 2}, Lihao Wang^{BC 2}, Hong Li^{BCF 2}, Qiang Zhang^{AEG 2*}

DOI: 10.12659/MSM.952169

Med Sci Monit 2026; 32:e952169

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 Prognostic significance of 7 protein signatures in HNSCC. Kaplan-Meier OS curves comparing high- and low-expression groups of CD45 (A), SETD2 (B), MERIT40_pS29 (C), BETACATENIN (D), RAPTOR (E), HER3_pY1289 (F), and Hexokinase-I (G). HNSCC – head and neck squamous cell carcinoma; OS – overall survival.

Back to the Article

RAPTOR Silencing Inhibits Head and Neck Squamous Cell Carcinoma Progression via Regulation of S100A8/A9 and Urokinase Plasminogen Activator

Your Privacy